• Twitter
GNS GNS
  • Leadership
  • Solutions
    • Drug Discovery Partnerships
    • Gemini Digital Twin
  • Publications
  • News
    • In the News
    • Events
    • Press Releases
    • Media Kit
  • Careers
    • Career Opportunities
    • Our Culture
  • Contact
Select Page

Evaluating Triple Therapy Treatment Pathways in Chronic Obstructive Pulmonary Disease (COPD): A Machine-Learning Predictive Model

by Zena Sfeir | Apr 11, 2022 | Articles, Causal, Clinical Trials, Featured Posts, Journals

Michael Bogart, Yuhang Liu, Todd Oakland, Marjorie Stiegler

The case for AI-driven cancer clinical trials – The efficacy arm in silico

by Zena Sfeir | May 31, 2021 | Articles, Causal, Clinical Trials, Featured Posts, Journals

Likhitha Kolla, Fred K. Gruber, Omar Khalid, Colin Hill, Ravi B. Parikh

GNS Healthcare Launches Gemini, the First In Silico Patient for Multiple Myeloma

by Simona Gilman | Jun 25, 2020 | Featured Posts, Press Releases

A transformative innovation GeminiTM, the in silico patient, will drive better drug development, clinical trial design and generation of real-world evidence in multiple myeloma GNS Healthcare, an AI-driven precision medicine company, today announced the launch of...

GNS Healthcare Launches Gemini, the First In Silico Patient for Multiple Myeloma

by Jerome Windsor | Jun 25, 2020 | Featured Posts, Press Releases

A transformative innovation GeminiTM, the in silico patient, will drive better drug development, clinical trial design and generation of real-world evidence in multiple myeloma GNS Healthcare, an AI-driven precision medicine company, today announced the launch of...
Diabetes Therapy: Application of Machine Learning Models to Evaluate Hypoglycemia Risk in Type 2 Diabetes

Diabetes Therapy: Application of Machine Learning Models to Evaluate Hypoglycemia Risk in Type 2 Diabetes

by Caitlin Nicholson | Feb 24, 2020 | Articles, Cardiometabolic, Causal, Featured Posts, Journals

Luke Mueller, Paulos Berhanu, Jonathan Bouchard, Veronica Alas, Kenneth Elder, Ngoc Thai, Cody Hitchcock, Tiffany Hadzi, Iya Khalil, Lesley-Ann Miller-Wilson
Nature Leukemia: Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease

Nature Leukemia: Multiple Myeloma DREAM Challenge reveals epigenetic regulator PHF19 as marker of aggressive disease

by Simona Gilman | Feb 18, 2020 | Articles, Featured Posts, Oncology

Mike J. Mason  ● Carolina Schinke ● Christine L. P. Eng ● Fadi Towfic ● Fred Gruber ● Andrew Dervan ● Brian S. White ● Aditya Pratapa ● Yuanfang Guan8 ● Hongjie Chen ● Yi Cui10 ● Bailiang Li ● Thomas Yu  ● Elias Chaibub Neto ● Konstantinos Mavrommatis  ● Maria Ortiz ●...
« Older Entries

Contact GNS

CONTACT US
    • ABOUT US
    • LEADERSHIP
    • SOLUTIONS
    • DRUG DISCOVERY PARTNERSHIPS
    • GEMINI DIGITAL TWIN
    • PUBLICATIONS
    • NEWS
    • IN THE NEWS
    • EVENTS
    • PRESS RELEASES
    • MEDIA KIT
    • CAREERS
    • CAREER OPPORTUNITIES
    • OUR CULTURE
    • CONTACT
    • Twitter
    © GNS Healthcare 561 Windsor St. A200, Somerville, MA 02143 | 617-374-2300
    This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
    Privacy & Cookies Policy

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
    Non-necessary
    Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
    SAVE & ACCEPT